SFM
BMRN icon

Soros Fund Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Soros Fund Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-156,053
Closed -$12.8M – 191
2024
Q2 		$12.8M Buy
156,053
+153
+0.1% +$12.7K 0.23% 102
2024
Q1 		$13.6M Buy
+155,900
New +$14M 0.23% 104
2017
Q3 		– Sell
-2,500
Closed -$227K – 234
2017
Q2 		$227K Buy
+2,500
New +$227K ﹤0.01% 188
2016
Q4 		– Sell
-5,734
Closed -$531K – 219
2016
Q3 		$531K Buy
+5,734
New +$540K 0.01% 163

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return